Long-Term (1 Year) Safety and Efficacy of Methylphenidate Modified-Release Long-Acting Formulation (MPH-LA) in Adults with Attention-Deficit Hyperactivity Disorder: A 26-Week, Flexible-Dose, Open-Label Extension to a 40-Week, Double-Blind, Randomised, Placebo-Controlled Core Study

INTRODUCTION: Previously, in a 40-week, randomised, double-blind, placebo-controlled core study comprising three phases (9-week dose confirmation, 5-week open-label dose optimisation and 6-month maintenance of effect) in adults with attention-deficit/hyperactivity disorder (ADHD), methylphenidate mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ginsberg, Y., Arngrim, T., Philipsen, A., Gandhi, P., Chen, C.-W., Kumar, V., Huss, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676085/
https://www.ncbi.nlm.nih.gov/pubmed/25183661
http://dx.doi.org/10.1007/s40263-014-0180-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676085/
https://www.ncbi.nlm.nih.gov/pubmed/25183661
http://dx.doi.org/10.1007/s40263-014-0180-4

Ejemplares similares